Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 4
2007 3
2008 2
2009 2
2015 3
2016 10
2017 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy.
Yan M, Wang C, He B, Yang M, Tong M, Long Z, Liu B, Peng F, Xu L, Zhang Y, Liang D, Lei H, Subrata S, Kelley KW, Lam EW, Jin B, Liu Q. Yan M, et al. Med Res Rev. 2016 Nov;36(6):1036-1079. doi: 10.1002/med.21399. Epub 2016 Jul 13. Med Res Rev. 2016. PMID: 27406026 Free article. Review.
Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins.
Guaita-Esteruelas S, Bosquet A, Saavedra P, Gumà J, Girona J, Lam EW, Amillano K, Borràs J, Masana L. Guaita-Esteruelas S, et al. Mol Carcinog. 2017 Jan;56(1):208-217. doi: 10.1002/mc.22485. Epub 2016 Apr 6. Mol Carcinog. 2017. PMID: 27061264 Free article.
Loss of Endometrial Plasticity in Recurrent Pregnancy Loss.
Lucas ES, Dyer NP, Murakami K, Lee YH, Chan YW, Grimaldi G, Muter J, Brighton PJ, Moore JD, Patel G, Chan JK, Takeda S, Lam EW, Quenby S, Ott S, Brosens JJ. Lucas ES, et al. Stem Cells. 2016 Feb;34(2):346-56. doi: 10.1002/stem.2222. Epub 2015 Dec 17. Stem Cells. 2016. PMID: 26418742 Free article. Clinical Trial.
Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype.
Zheng F, Yue C, Li G, He B, Cheng W, Wang X, Yan M, Long Z, Qiu W, Yuan Z, Xu J, Liu B, Shi Q, Lam EW, Hung MC, Liu Q. Zheng F, et al. Nat Commun. 2016 Jan 19;7:10180. doi: 10.1038/ncomms10180. Nat Commun. 2016. PMID: 26782714 Free PMC article.
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.
Marzi L, Combes E, Vié N, Ayrolles-Torro A, Tosi D, Desigaud D, Perez-Gracia E, Larbouret C, Montagut C, Iglesias M, Jarlier M, Denis V, Linares LK, Lam EW, Martineau P, Del Rio M, Gongora C. Marzi L, et al. Br J Cancer. 2016 Nov 8;115(10):1223-1233. doi: 10.1038/bjc.2016.313. Epub 2016 Sep 29. Br J Cancer. 2016. PMID: 27685445 Free PMC article.
FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance.
Nestal de Moraes G, Delbue D, Silva KL, Robaina MC, Khongkow P, Gomes AR, Zona S, Crocamo S, Mencalha AL, Magalhães LM, Lam EW, Maia RC. Nestal de Moraes G, et al. Cell Signal. 2015 Dec;27(12):2496-505. doi: 10.1016/j.cellsig.2015.09.013. Epub 2015 Sep 25. Cell Signal. 2015. PMID: 26404623
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer.
Francis RE, Myatt SS, Krol J, Hartman J, Peck B, McGovern UB, Wang J, Guest SK, Filipovic A, Gojis O, Palmieri C, Peston D, Shousha S, Yu Q, Sicinski P, Coombes RC, Lam EW. Francis RE, et al. Int J Oncol. 2009 Jul;35(1):57-68. doi: 10.3892/ijo_00000313. Int J Oncol. 2009. PMID: 19513552 Free PMC article.
Many forks in the path: cycling with FoxO.
Ho KK, Myatt SS, Lam EW. Ho KK, et al. Oncogene. 2008 Apr 7;27(16):2300-11. doi: 10.1038/onc.2008.23. Oncogene. 2008. PMID: 18391972 Review.
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.
Sundriyal S, Moniot S, Mahmud Z, Yao S, Di Fruscia P, Reynolds CR, Dexter DT, Sternberg MJ, Lam EW, Steegborn C, Fuchter MJ. Sundriyal S, et al. J Med Chem. 2017 Mar 9;60(5):1928-1945. doi: 10.1021/acs.jmedchem.6b01690. Epub 2017 Feb 15. J Med Chem. 2017. PMID: 28135086 Free PMC article.
Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.
McGovern UB, Francis RE, Peck B, Guest SK, Wang J, Myatt SS, Krol J, Kwok JM, Polychronis A, Coombes RC, Lam EW. McGovern UB, et al. Mol Cancer Ther. 2009 Mar;8(3):582-91. doi: 10.1158/1535-7163.MCT-08-0805. Epub 2009 Mar 10. Mol Cancer Ther. 2009. PMID: 19276163 Free article.
23 results
Jump to page
Feedback